INS and type 2 diabetes mellitus: For example, IL-1 receptor antagonist (IL-1Ra) treatment decreased immune cell invasion into the pancreatic islets and improved glycemic control and insulin secretion in GK rats, a spontaneous, non-obese type 2 diabetes model [83].